The Efficacy of Transdermal Rivastigmine in Mild to Moderate Alzheimer’s Disease with Concomitant Small Vessel Cerebrovascular Disease: Findings from an Open-Label Study
Chathuri Yatawara,1 Fatin Zahra Zailan,1 Esther Vanessa Chua,1 Linda Lay Hoon Lim,1 Eveline Silva,1 Joanna Sihan Wang,1 Adeline Ng,1 Kok Pin Ng,1 Nagaendran Kandiah1– 3 1Department of Neurology, National Neuroscience Institute, Singapore, Singapore; 2Duke-NUS Medical School, Singapore, Sin...
Enregistré dans:
Auteurs principaux: | Yatawara C, Zailan FZ, Chua EV, Lim LLH, Silva E, Wang JS, Ng A, Ng KP, Kandiah N |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/77088d6a53fd4ec4be41f84146f8313f |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia
par: Kandiah N, et autres
Publié: (2017) -
Cerebrovascular diseases
Publié: (1990) -
The Potential Effect of Insulin on AChE and Its Interactions with Rivastigmine In Vitro
par: Tahereh Jamshidnejad-Tosaramandani, et autres
Publié: (2021) -
Dementia in Southeast Asia: influence of onset-type, education, and cerebrovascular disease
par: Ashwati Vipin, et autres
Publié: (2021) -
Hypertension, BMI, and cardiovascular and cerebrovascular diseases
par: Qiao Wenjing, et autres
Publié: (2021)